Pharmaceuticals

Cystic Fibrosis (CF) Therapeutics Market Trends 2025–2029: Forecasts for Key Growth Segments

November 10, 2025 by Marketing Posting

Unlock Global Insights – Save 20% on Market Reports with Code ONLINE20

What Is The Anticipated Size Of The Cystic Fibrosis (CF) Therapeutics Market Over The Five-Year Period 2025–2029?

The cystic fibrosis (CF) therapeutics market has seen substantial growth over recent years. It is anticipated to increase from $7.63 billion in 2024 to $8.34 billion in 2025, exhibiting a compound annual growth rate (CAGR) of 9.3%. This historical expansion can be attributed to several factors, including advancements in targeted therapies, an expanding comprehension of CF genetics, heightened patient advocacy and awareness efforts, government funding for research, the granting of orphan drug designations, and incentives promoting research into rare diseases.

The cystic fibrosis (CF) therapeutics market size is anticipated to expand significantly in the coming years. It is forecast to achieve a value of $10.92 billion by 2029, growing at a compound annual growth rate (CAGR) of 7.0%. This growth during the forecast period is influenced by a rising CF patient population, regulatory approvals for new therapies, a focus on personalized medicine, increased investment in biomarker research, expanded newborn screening programs, and supportive healthcare policy. Prominent trends expected in this period include the wider use of CFTR modulators, the emergence of gene editing technologies, the adoption of early intervention strategies, advancements in diagnostic techniques, the growth of telehealth and remote monitoring, increasing healthcare digitalization, and improved chronic disease management.

Unlock Your Free Sample Report for Exclusive Market Data:

https://www.thebusinessresearchcompany.com/sample.aspx?id=9056&type=smp

What Are The Drivers Pushing New Developments In The Cystic Fibrosis (CF) Therapeutics Market?

The increasing prevalence of cystic fibrosis (CF) is anticipated to fuel the expansion of the cystic fibrosis (CF) therapeutics market. Cystic fibrosis (CF) is an inherited condition that causes severe damage to the lungs, digestive system, and other organs, with its therapeutics designed to thin lung mucus for easier clearance. The escalating number of individuals affected by cystic fibrosis is thus poised to propel the cystic fibrosis (CF) therapeutics market. For example, a July 2022 report from The Cystic Fibrosis (CF) Foundation highlighted a growing incidence of cystic fibrosis, noting that in 2022, nearly 40,000 children and adults in the United States and over 105,000 people worldwide were diagnosed. This upward trend in cystic fibrosis patients is therefore a primary factor driving the growth of the cystic fibrosis (CF) therapeutics market.

What Are The Emerging Segments Gaining Attention In The Cystic Fibrosis (CF) Therapeutics Market?

The cystic fibrosis (cf) therapeutics market covered in this report is segmented –

1) By Drug Class: Pancreatic Enzyme Supplements, Mucolytic, Bronchodilators, CFTR Modulators

2) By Route Of Administration: Oral, Inhaled

3) By Treatment Method: Medication, Devices

Subsegments:

1) By Pancreatic Enzyme Supplements: Lipase, Amylase, Protease

2) By Mucolytics: Dornase Alfa (Pulmozyme), Hypertonic Saline

3) By Bronchodilators: Short-Acting Beta Agonists (SABAs), Long-Acting Beta Agonists (LABAs), Anticholinergics

4) By CFTR Modulators: Ivacaftor, Lumacaftor Or Ivacaftor (Orkambi), Tezacaftor Or Ivacaftor (Symdeko), Elexacaftor Or Tezacaftor Or Ivacaftor

What Are The Major Trends Driving The Growth Of The Cystic Fibrosis (CF) Therapeutics Market?

Major companies operating in the cystic fibrosis (CF) therapeutics market are advancing treatment and patient care solutions, such as the cystic fibrosis innovation hub network, to speed up research, refine treatment options, and strengthen collaboration in developing new therapies for CF patients. The cystic fibrosis innovation hub network is a cooperative platform or program specifically designed to accelerate the research and development of novel treatments for cystic fibrosis (CF). For instance, in October 2024, LifeArc, a UK-based charity and life sciences company dedicated to translating scientific research into practical healthcare solutions, launched the UK’s inaugural Cystic Fibrosis Innovation Hub Network. The Cystic Fibrosis Innovation Hub Network is structured to enhance research and development for cystic fibrosis (CF) treatments, promoting collaboration among healthcare providers, researchers, and patients. Introduced as part of a broader effort to quicken innovation in cystic fibrosis therapies, the hub concentrates on identifying new pathways for drug development and improving patient outcomes.

Which Leading Players Are Enhancing Their Cystic Fibrosis (CF) Therapeutics Market Presence Worldwide?

Major companies operating in the cystic fibrosis (CF) therapeutics market include Teva Pharmaceutical Industries Ltd., F. Hoffmann-La Roche AG, Vertex Pharmaceuticals Incorporated, Chiesi Farmaceutici SpA, PTC Therapeutics LIMITED, Genentech Inc., Alaxia, AstraZeneca, Beyond Air Inc., Pfizer Inc., Alcresta Therapeutics Inc., Laurent Pharmaceuticals, Nestlé HealthScience, Pharmaxis, Bayer AG, AbbVie Inc., Novartis AG, Arcturus Therapeutics Holdings Inc., Arrowhead Pharmaceuticals Inc, ProQR Therapeutics N.V., Enterprise Therapeutics Ltd. , Corbus Pharmaceuticals Holdings Inc, Eloxx Pharmaceuticals , Translate Bio Inc, Zambon S.p.A

Download The Full Report For Exclusive Market Findings:

https://www.thebusinessresearchcompany.com/report/cystic-fibrosis-cf-therapeutics-global-market-report

Which Region Is Expected To Witness The Fastest Growth In The Cystic Fibrosis (CF) Therapeutics Market?

North America was the largest region in the cystic fibrosis (CF) therapeutics market in 2024. Asia-Pacific is expected to be the fastest-growing region in the cystic fibrosis (CF) therapeutics market during the forecast period. The regions covered in the cystic fibrosis (CF) therapeutics market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

Request A Customized Version Of The Cystic Fibrosis (CF) Therapeutics Market Report:

https://www.thebusinessresearchcompany.com/customise?id=9056&type=smp

Browse Through More Reports Similar to the Global Cystic Fibrosis (CF) Therapeutics Market 2025, By The Business Research Company

Blood Cancer Drugs Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/blood-cancer-drugs-global-market-report

Cancer Biologics Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/cancer-biologics-global-market-report

Rituximab Biosimilar Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/rituximab-biosimilar-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795